Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Menarini International Operations Luxembourg S.A., 1, Avenue de la Gare, L-1611 Luxembourg, Luxembourg
Ilaxten 20 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Oval biconvex scored white tablets (length 10 mm, width 5 mm). The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each tablet contains 20 mg of bilastine.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Bilastine |
Bilastine is a non-sedating, long-acting histamine antagonist with selective peripheral Η1 receptor antagonist affinity and no affinity for muscarinic receptors. |
| List of Excipients |
|---|
|
Cellulose, microcrystalline |
The medicinal product is packaged in a blister, consisting of two parts:
The aluminium foil is thermosealed with a heat-seal lacquer (PVC-PVAC copolymer and resins of butylmethacrylate) to the laminate after molding and filling of the tablets.
Each blister contains 10 tablets. The blisters are packaged in cardboard boxes.
Pack sizes: 10, 20, 30, 40 or 50 tablets.
Not all pack sizes may be marketed.
Menarini International Operations Luxembourg S.A., 1, Avenue de la Gare, L-1611 Luxembourg, Luxembourg
PL 16239/0034
Date of first authorisation: 08/10/2010
Date of latest renewal: 08/09/2015
| Drug | Countries | |
|---|---|---|
| ILAXTEN | United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
